We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > immuno-oncology

News List

SOTIO Appoints Richard Sachse as Chief Medical Officer b3cnewswire
July 01, 2020
SOTIO, a clinical stage immuno-oncology company owned by PPF Group, today announced the appointment of Richard Sachse, M.D., Ph.D., as Chief Medical Officer effective July 1, 2020. Dr. Sachse brings more than 25 years of experience in the biopharma indust
Lilly boosts immuno-oncology pipeline with $1.6B Armo buy fiercebiotech
May 16, 2018
Eli Lilly is ponying up about $1.6 billion to get its hands on Armo Biosciences and its lead asset, pegilodecakin, which has shown promise both as a single agent and in combination treatments for multiple tumor types.
Certara Launches Industry-First Quantitative Systems Pharmacology (QSP) Consortium on Immuno-oncolog biospace
March 14, 2018
Certara®, the global leader in model-informed drug development and regulatory science, today announced the launch of its Quantitative Systems Pharmacology (QSP) Immuno-oncology Simulator Consortium.
Five Prime cuts loose from InhibRx immuno-oncology deal fiercepharma
August 30, 2017
Five Prime hands back rights to GITR program including lead candidate FPA-154